2025-04-16-世界卫生组织-The_impact_of_suspensions_and_reductions_in_official_development_assistance_on_HIV,_hepatitis_and_STIs_5页_400kb

Summary of WHO Reports on Impact of Suspensions and Reductions in Official Development Assistance

The reports focus on the consequences of paused or reduced foreign aid from the US Government and other sources, particularly on health services for HIV, hepatitis, and STIs.

• Strategic Information and Analytics Report No 1 (April 2025): This survey examined continuity of essential health services in 55 US-reliant Member States. It identified significant service disruptions among key populations for HIV, prevention services, testing, and treatment. The data serves as a baseline to estimate short and long-term impacts on HIV mortality and new infections and informs targeted interventions.

• Rapid WHO Stock Take (March-April 2025): Conducted across 108 WHO offices, this assessment revealed severe health system disruptions due to aid suspensions. Key findings include:

  • At least 71% of countries experienced service interruptions; 48% reported moderate to severe HIV service disruptions, 43% for STIs, and 38% for viral hepatitis services.
  • Medicine shortages affected over 36% of countries for HIV products, 34% for STI products, and 29% for hepatitis products.
  • Job losses impacted health workers in over half of responding countries, including community health workers, doctors, nurses, and administrators; budget cuts led to increased out-of-pocket expenses in one-fourth of countries.
  • Information systems were disrupted in over 40% of countries; most nations paused operational workplans and partner activities due to aid freezes.
  • Common mitigations include reallocating funds, integrating services, and strengthening partnerships, while countries are seeking actions like enhanced coordination and resource mobilization for vital health services.

Despite these challenges, countries are addressing gaps and coordinating efforts. Both reports underscore an urgent need for innovative financing, technical assistance, and strengthened systems to avoid catastrophic health outcomes.